Agreement secured with Ilara Health to sell ResAppDx in Kenya

View printer-friendly version Ilara Health appointed to promote, market and sell ResAppDx in Kenya Ilara provides access to a large potential customer base in Kenya and has established partnerships with over 250 primary care clinics across the country Agreement...

ResApp secures firm commitments to raise $5.5 million

View printer-friendly version Brisbane, Australia, 12 April 2021 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to advise that is has...

TGA clearance achieved for wearable

View printer-friendly version Brisbane, Australia, 25 March 2021 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to advise that it has...